Restructuring Of Indian Pharmaceutical Companies PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Restructuring Of Indian Pharmaceutical Companies PDF full book. Access full book title Restructuring Of Indian Pharmaceutical Companies by Sneha Shankar. Download full books in PDF and EPUB format.
Author: Sneha Shankar
Publisher:
ISBN: 9786903897633
Category : Medical
Languages : en
Pages : 0
Get Book Here
Book Description
Corporate Restructuring is a significant managerial decision to modify the financial structure of the firm. This concept of Corporate Restructuring has evolved with the purpose of achieving the excellence of business and creating the value to different stakeholders of the business. Corporate Restructuring plays significant role in improving the efficiency and profitability of the business. It is the tool used by the firms to consolidate the operations of business and strengthen their position for attaining the corporate objectives and synergies. Adopting the strategic tools such as corporate restructuring for implementing the best practices in the business has become very essential for the consistent improvement in the performance of business and value of the firm. The present study is an empirical analysis of Corporate Restructuring in Indian Pharmaceutical Industry of select firms listed in National Stock Exchange. The study attempted to examine the performance of selected forms of corporate restructuring in Indian Pharmaceutical Industry. The researcher has collected the data of selected deals from Capitaline Database. The data of the study has been collected for a period of 10 years from 2011 to 2020. The samples of 6 deals are chosen for the analysis.
Author: Sneha Shankar
Publisher:
ISBN: 9786903897633
Category : Medical
Languages : en
Pages : 0
Get Book Here
Book Description
Corporate Restructuring is a significant managerial decision to modify the financial structure of the firm. This concept of Corporate Restructuring has evolved with the purpose of achieving the excellence of business and creating the value to different stakeholders of the business. Corporate Restructuring plays significant role in improving the efficiency and profitability of the business. It is the tool used by the firms to consolidate the operations of business and strengthen their position for attaining the corporate objectives and synergies. Adopting the strategic tools such as corporate restructuring for implementing the best practices in the business has become very essential for the consistent improvement in the performance of business and value of the firm. The present study is an empirical analysis of Corporate Restructuring in Indian Pharmaceutical Industry of select firms listed in National Stock Exchange. The study attempted to examine the performance of selected forms of corporate restructuring in Indian Pharmaceutical Industry. The researcher has collected the data of selected deals from Capitaline Database. The data of the study has been collected for a period of 10 years from 2011 to 2020. The samples of 6 deals are chosen for the analysis.
Author: R. K. Mishra
Publisher: Mittal Publications
ISBN: 9788170998716
Category : Business and politics
Languages : en
Pages : 254
Get Book Here
Book Description
Author: Reji K. Joseph
Publisher: Routledge
ISBN: 1317408829
Category : Business & Economics
Languages : en
Pages : 192
Get Book Here
Book Description
This book examines the impact of economic reforms in India on the pharmaceutical industry and access to medicines. It traces the changing production and trade pattern of the industry, research and development (R&D) preferences and strategies of Indian pharmaceutical firms, patent system alongside pricing policy measures and their shortcomings. It also analyses the public health financing system in India driven largely by out-of-pocket expenditure — about 60 per cent — and characterised by very high share of medicines in total health expenditure. A masterful insight into a topical area, the work will be indispensable to those working on pharmaceutical industry and public policy. It will be of interest to researchers, scholars, students, and policy-makers of economics, industrial policy, public policy, intellectual property rights and health financing.
Author: B Rajesh Kumars M Satish
Publisher: ICFAI Books
ISBN: 8131407578
Category : Business planning
Languages : en
Pages : 412
Get Book Here
Book Description
The pharmaceutical industry in India is one of the largest and most advanced among the developing countries. During the last three decades, Indian pharmaceutical industry achieved spectacular progress by any standard. India s pharmaceutical industry has b
Author: Aas Mohammad
Publisher: Cambridge Scholars Publishing
ISBN: 1527540391
Category : Business & Economics
Languages : en
Pages : 224
Get Book Here
Book Description
This book evaluates the performance of the Indian pharmaceutical industry, which plays an important role in economic development. It highlights the role the government has had in facilitating the growth of the industry from non-existence, before the 1970s, to being one of the largest pharmaceutical industries in the world today. The text employs various useful techniques to provide an understanding of productivity and efficiency, such as data envelopment analysis, stochastic frontier analysis, the Malmquist Productivity Index and the Hicks-Moorsteen Productivity Index. The book will be useful to health administrators, students of public policy, and health economists with an interest in the pharmaceutical sector.
Author: Dr. Sandeep Tare
Publisher: Lulu.com
ISBN: 0359085512
Category :
Languages : en
Pages : 280
Get Book Here
Book Description
Author: Graham Dutfield
Publisher: Routledge
ISBN: 1136536280
Category : Law
Languages : en
Pages : 273
Get Book Here
Book Description
Biogenetic resources - the critical biological and chemical materials that underpin so much of medicine, both modern and traditional, agriculture, and wider economic activity in so many fields - are at the centre of heated debate regarding their use, development, and ownership, and the issues of ethics and equity that impinge on all of these factors. This book is a comprehensive examination of the key issues, institutions and ideologies in this area, presenting definitions and explanations of the fundamentals of intellectual property rights (IPRs), biogenetic resources and traditional knowledge. It uses the insights from this to build a picture of how these factors interact in practice, bringing to the surface issues such as: the conservation and sustainable use of biodiversity, benefit sharing from the commercial use of biodiversity, biotechnological innovation and the transfer of technology, agriculture, food security, rural development, health and international justice. Part 1 describes the relevant international IPR laws, highlights the extent to which modern commerce depends on such resources, and traces the way in which modern IPR law has evolved to accommodate this dependence. Part 2 shows how stronger IPR protection in the area of life science innovation has given rise to controversies such as 'biopiracy', 'terminator' genes and genetic uniformity. Part 3 focuses on traditional knowledge, its nature, its importance, and the applicability of IPR-style protection. Part 4 covers the international negotiation and policy-making of the WTO, WIPO and CBD and the legislative initiatives of national governments of Asia, Africa and Latin America. Finally, Part 5 focuses on two developing country case studies - of India and Kenya - assessing whether they will be able to gain economic benefit from development of their natural resources within the current regulatory system and whether this will encourage the conservation and sustainable use of the resource base. With its multidisciplinary approach and breadth of coverage, this book will appeal both to those new to the subject and to those with professional and specialist interest, including students, academics, legal practitioners, government policy-makers and the private sector.
Author: Subba Rao Chaganti
Publisher: PharmaMed Press / BSP Books
ISBN: 9388305264
Category : Medical
Languages : en
Pages : 720
Get Book Here
Book Description
Pharmaceutical Marketing in India: For Today and Tomorrow is the go-to guide for anyone interested in the pharmaceutical industry in India. With its comprehensive coverage of the sector, this book is a must-read for students, practitioners, and researchers alike. In this updated 25th Anniversary Edition, readers will find new content that covers the latest trends and initiatives in the industry. The book provides a thorough introduction to the changes taking place in first-world markets and the incremental steps being taken by Indian drug majors and their MNC counterparts in India. This book contains seventy-seven cases that highlight the best practices of successful practitioners of Pharma marketing in India. These cases showcase how they have positioned their products, launched and promoted their brands, and defended their therapeutic segments. The insights provided by these cases are incredibly valuable to both practitioners and students of pharmaceutical marketing. The new edition of the book includes information on changing detailing practices such as e-Detailing, iPad detailing, and tablet detailing, digital marketing strategies, social media strategies for the pharmaceutical industry, multichannel marketing, closed-loop marketing, and more. It also covers the latest ways of engaging and building meaningful relationships with physicians, including medical sales liaisons (MSL), key opinion leader (KOL) management, and key account management (KAM). The primary purpose of this edition is to make it not only relevant for today but also for tomorrow. In other words, to make it as future-proof as possible. This book is a vital resource for anyone interested in the pharmaceutical industry and is a must-read for those looking to stay ahead of the curve in this ever-evolving field. Contents: Part One: The Big Picture 1. The Indian Pharmaceutical Industry: An Overview 2. The Pharmaceutical Market Part Two: Ten ‘P’s 3. The Product 4. The Price 5. The Place 6. The Promotion 7. Personal selling 8. The Prescription 9. The Policy 10. Public Relations 11. The Power 12. The Patient Part Three: Key Success Factors 13. Managing New Products 14. The Winning Game Plans 15. Towards Excellence in Marketing 16. The Winning Edge 17. Corporate Scoreboard 18. GMP
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Get Book Here
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author: P. L. Beena
Publisher: Routledge
ISBN: 1317590902
Category : Business & Economics
Languages : en
Pages : 208
Get Book Here
Book Description
This book provides a holistic account of developments and patterns of mergers and acquisitions that have taken place in the Indian corporate sector, especially in the post-liberalisation era. It combines astute analyses with up-to-date data to present an all-inclusive picture of globalisation and its impact on business in contemporary India. This will serve as an important resource to researchers, scholars and students of economics, management, business administration, business studies, commerce and corporate law, as well as policy-makers, legal practitioners, industrial houses, and industrial bodies.
